{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T04:08:23Z","timestamp":1748578103373,"version":"3.41.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,29]]},"DOI":"10.7759\/cureus.85040","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T17:09:57Z","timestamp":1748538597000},"source":"Crossref","is-referenced-by-count":0,"title":["Development and Evaluation of Oro-Mucosal Drug Delivery System for the Effective Management of Oropharyngeal Candidiasis: An Animal Study"],"prefix":"10.7759","author":[{"given":"Prakhar","family":"Kapoor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Revati S","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rizwan M","family":"Sanadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamolie S","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2012.08.002","article-title":"Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility","volume":"22","author":"Bulacio L","year":"2012","unstructured":"Bulacio L, Paz M, Ramad\u00e1n S, et al.. Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility. J Mycol Med. 2012, 22:348-53. 10.1016\/j.mycmed.2012.08.002","journal-title":"J Mycol Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2010.03.001","article-title":"Photodynamic inactivation of normal and antifungal resistant Candida species","volume":"7","author":"Mang TS","year":"2010","unstructured":"Mang TS, Mikulski L, Hall RE. Photodynamic inactivation of normal and antifungal resistant Candida species. Photodiagnosis Photodyn Ther. 2010, 7:98-105. 10.1016\/j.pdpdt.2010.03.001","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2003.09.022","article-title":"Bioadhesive, non-drug-loaded nanoparticles as modulators of candidal adherence to buccal epithelial cells: a potentially novel prophylaxis for candidosis","volume":"25","author":"McCarron PA","year":"2004","unstructured":"McCarron PA, Donnelly RF, Canning PE, McGovern JG, Jones DS. Bioadhesive, non-drug-loaded nanoparticles as modulators of candidal adherence to buccal epithelial cells: a potentially novel prophylaxis for candidosis. Biomaterials. 2004, 25:2399-407. 10.1016\/j.biomaterials.2003.09.022","journal-title":"Biomaterials"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2015.07.065","article-title":"Antifungal activity against Candida albicans of starch Pickering emulsion with thymol or amphotericin B in suspension and calcium alginate films","volume":"493","author":"Cossu A","year":"2015","unstructured":"Cossu A, Wang MS, Chaudhari A, Nitin N. Antifungal activity against Candida albicans of starch Pickering emulsion with thymol or amphotericin B in suspension and calcium alginate films. Int J Pharm. 2015, 493:233-42. 10.1016\/j.ijpharm.2015.07.065","journal-title":"Int J Pharm"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.14.2.398-429.2001","article-title":"Experimental oral candidiasis in animal models","volume":"14","author":"Samaranayake YH","year":"2001","unstructured":"Samaranayake YH, Samaranayake LP. Experimental oral candidiasis in animal models. Clin Microbiol Rev. 2001, 14:398-429. 10.1128\/CMR.14.2.398-429.2001","journal-title":"Clin Microbiol Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200212000-00017","article-title":"Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants","volume":"21","author":"Goins RA","year":"2002","unstructured":"Goins RA, Ascher D, Waecker N, Arnold J, Moorefield E. Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants. Pediatr Infect Dis J. 2002, 21:1165-7. 10.1097\/00006454-200212000-00017","journal-title":"Pediatr Infect Dis J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn401","article-title":"Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment","volume":"62","author":"Hachem RY","year":"2008","unstructured":"Hachem RY, Langston AA, Graybill JR, Perfect JR, Pedicone LD, Patino H, Raad II. Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment. J Antimicrob Chemother. 2008, 62:1386-91. 10.1093\/jac\/dkn401","journal-title":"J Antimicrob Chemother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-008-9166-1","article-title":"Design and in vitro\/in vivo evaluation of novel mucoadhesive buccal discs of an antifungal drug: relationship between swelling, erosion, and drug release","volume":"9","author":"Yehia SA","year":"2008","unstructured":"Yehia SA, El-Gazayerly ON, Basalious EB. Design and in vitro\/in vivo evaluation of novel mucoadhesive buccal discs of an antifungal drug: relationship between swelling, erosion, and drug release. AAPS PharmSciTech. 2008, 9:1207-17. 10.1208\/s12249-008-9166-1","journal-title":"AAPS PharmSciTech"},{"key":"ref9","article-title":"Preparation of fluconazole buccal tablet and influence of formulation expedients on its properties","volume":"46","author":"Mohamed SP","year":"2011","unstructured":"Mohamed SP, Muzzammil S, Pramod KT. Preparation of fluconazole buccal tablet and influence of formulation expedients on its properties. Yao Xue Xue Bao. 2011, 46:460-5.","journal-title":"Yao Xue Xue Bao"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1208\/pt050335","article-title":"Preparation and evaluation of a novel buccal adhesive system","volume":"5","author":"Desai KG","year":"2004","unstructured":"Desai KG, Kumar TM. Preparation and evaluation of a novel buccal adhesive system. AAPS PharmSciTech. 2004, 5:e35. 10.1208\/pt050335","journal-title":"AAPS PharmSciTech"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.12.008","article-title":"Efficient mucus permeation and tight junction opening by dissociable \"mucus-inert\" agent coated trimethyl chitosan nanoparticles for oral insulin delivery","volume":"222","author":"Liu M","year":"2016","unstructured":"Liu M, Zhang J, Zhu X, et al.. Efficient mucus permeation and tight junction opening by dissociable \"mucus-inert\" agent coated trimethyl chitosan nanoparticles for oral insulin delivery. J Control Release. 2016, 222:67-77. 10.1016\/j.jconrel.2015.12.008","journal-title":"J Control Release"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24142","article-title":"Mucoadhesive films containing chitosan-coated nanoparticles: a new strategy for buccal curcumin release","volume":"103","author":"Mazzarino L","year":"2014","unstructured":"Mazzarino L, Borsali R, Lemos-Senna E. Mucoadhesive films containing chitosan-coated nanoparticles: a new strategy for buccal curcumin release. J Pharm Sci. 2014, 103:3764-71. 10.1002\/jps.24142","journal-title":"J Pharm Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051x.1997.tb00203.x","article-title":"An investigation of bioadhesion for periodontal and oral mucosal drug delivery","volume":"24","author":"Needleman IG","year":"1997","unstructured":"Needleman IG, Smales FC, Martin GP. An investigation of bioadhesion for periodontal and oral mucosal drug delivery. J Clin Periodontol. 1997, 24:394-400. 10.1111\/j.1600-051x.1997.tb00203.x","journal-title":"J Clin Periodontol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3109\/21691401.2014.948548","article-title":"Advances in preparation and characterization of chitosan nanoparticles for therapeutics","volume":"44","author":"Chandra Hembram K","year":"2016","unstructured":"Chandra Hembram K, Prabha S, Chandra R, Ahmed B, Nimesh S. Advances in preparation and characterization of chitosan nanoparticles for therapeutics. Artif Cells Nanomed Biotechnol. 2016, 44:305-14. 10.3109\/21691401.2014.948548","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2018.04.122","article-title":"Chitosan coated PLGA nanoparticles amplify the ocular hypotensive effect of forskolin: Statistical design, characterization and in vivo studies","volume":"116","author":"Khan N","year":"2018","unstructured":"Khan N, Ameeduzzafar, Khanna K, Bhatnagar A, Ahmad FJ, Ali A. Chitosan coated PLGA nanoparticles amplify the ocular hypotensive effect of forskolin: Statistical design, characterization and in vivo studies. Int J Biol Macromol. 2018, 116:648-63. 10.1016\/j.ijbiomac.2018.04.122","journal-title":"Int J Biol Macromol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S103762","article-title":"Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis","volume":"11","author":"Ren\u00e7ber S","year":"2016","unstructured":"Ren\u00e7ber S, Karavana SY, Y\u0131lmaz FF, et al.. Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis. Int J Nanomedicine. 2016, 11:2641-53. 10.2147\/IJN.S103762","journal-title":"Int J Nanomedicine"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3109\/10837450.2014.979942","article-title":"Amphotericin B-loaded polymeric nanoparticles: formulation optimization by factorial design","volume":"21","author":"Carraro TC","year":"2016","unstructured":"Carraro TC, Khalil NM, Mainardes RM. Amphotericin B-loaded polymeric nanoparticles: formulation optimization by factorial design. Pharm Dev Technol. 2016, 21:140-6. 10.3109\/10837450.2014.979942","journal-title":"Pharm Dev Technol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e03451","article-title":"A comparison of models for the analysis of the kinetics of drug release from PLGA-based nanoparticles","volume":"6","author":"Pourtalebi Jahromi L","year":"2020","unstructured":"Pourtalebi Jahromi L, Ghazali M, Ashrafi H, Azadi A. A comparison of models for the analysis of the kinetics of drug release from PLGA-based nanoparticles. Heliyon. 2020, 6:e03451. 10.1016\/j.heliyon.2020.e03451","journal-title":"Heliyon"},{"key":"ref19","article-title":"Candidiasis","author":"Arya NR","year":"2025","unstructured":"Arya NR, Rafiq NB. Candidiasis. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.844069","article-title":"Epidemiology and prevalence of oral candidiasis in HIV patients from chad in the Post-HAART era","volume":"13","author":"Taverne-Ghadwal L","year":"2022","unstructured":"Taverne-Ghadwal L, Kuhns M, Buhl T, et al.. Epidemiology and prevalence of oral candidiasis in HIV patients from chad in the Post-HAART era. Front Microbiol. 2022, 13:844069. 10.3389\/fmicb.2022.844069","journal-title":"Front Microbiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(94)90300-x","article-title":"Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance","volume":"97","author":"Sangeorzan JA","year":"1994","unstructured":"Sangeorzan JA, Bradley SF, He X, Zarins LT, Ridenour GL, Tiballi RN, Kauffman CA. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med. 1994, 97:339-46. 10.1016\/0002-9343(94)90300-x","journal-title":"Am J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.9.3135-3139.2002","article-title":"Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole","volume":"40","author":"Martinez M","year":"2002","unstructured":"Martinez M, L\u00f3pez-Ribot JL, Kirkpatrick WR, Coco BJ, Bachmann SP, Patterson TF. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole. J Clin Microbiol. 2002, 40:3135-9. 10.1128\/JCM.40.9.3135-3139.2002","journal-title":"J Clin Microbiol"},{"key":"ref23","article-title":"Oropharyngeal candidiasis: diagnostic clues, treatment tips","volume":"29","author":"Klotz SA","year":"2008","unstructured":"Klotz SA, Nand K, Gaur NK, Lipke PN. Oropharyngeal candidiasis: diagnostic clues, treatment tips. J Respir Dis. 2008, 29:128-35.","journal-title":"J Respir Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/825901","article-title":"Posaconazole: a new agent for the prevention and management of severe, refractory or invasive fungal infections","volume":"19","author":"Page AV","year":"2008","unstructured":"Page AV, Liles WC. Posaconazole: a new agent for the prevention and management of severe, refractory or invasive fungal infections. Can J Infect Dis Med Microbiol. 2008, 19:297-305. 10.1155\/2008\/825901","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.10.3690-3696.2004","article-title":"Posaconazole is a potent inhibitor of sterol 14alpha-demethylation in yeasts and molds","volume":"48","author":"Munayyer HK","year":"2004","unstructured":"Munayyer HK, Mann PA, Chau AS, et al.. Posaconazole is a potent inhibitor of sterol 14alpha-demethylation in yeasts and molds. Antimicrob Agents Chemother. 2004, 48:3690-6. 10.1128\/AAC.48.10.3690-3696.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2004.01.005","article-title":"Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study","volume":"21","author":"Wexler D","year":"2004","unstructured":"Wexler D, Courtney R, Richards W, Banfield C, Lim J, Laughlin M. Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study. Eur J Pharm Sci. 2004, 21:645-53. 10.1016\/j.ejps.2004.01.005","journal-title":"Eur J Pharm Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00163-06","article-title":"In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts","volume":"50","author":"Sabatelli F","year":"2006","unstructured":"Sabatelli F, Patel R, Mann PA, et al.. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother. 2006, 50:2009-15. 10.1128\/AAC.00163-06","journal-title":"Antimicrob Agents Chemother"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.09.015","article-title":"Posaconazole: an extended-spectrum triazole antifungal agent","volume":"29","author":"Schiller DS","year":"2007","unstructured":"Schiller DS, Fung HB. Posaconazole: an extended-spectrum triazole antifungal agent. Clin Ther. 2007, 29:1862-86. 10.1016\/j.clinthera.2007.09.015","journal-title":"Clin Ther"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2147\/idr.s10588","article-title":"Role of posaconazole in the treatment of oropharyngeal candidiasis","volume":"3","author":"Ianas V","year":"2010","unstructured":"Ianas V, Matthias KR, Klotz SA. Role of posaconazole in the treatment of oropharyngeal candidiasis. Infect Drug Resist. 2010, 3:45-51. 10.2147\/idr.s10588","journal-title":"Infect Drug Resist"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2007.11928283","article-title":"Posaconazole (Noxafil): a new triazole antifungal agent","volume":"20","author":"Greer ND","year":"2007","unstructured":"Greer ND. Posaconazole (Noxafil): a new triazole antifungal agent. Proc (Bayl Univ Med Cent). 2007, 20:188-96. 10.1080\/08998280.2007.11928283","journal-title":"Proc (Bayl Univ Med Cent)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/335901-development-and-evaluation-of-oro-mucosal-drug-delivery-system-for-the-effective-management-of-oropharyngeal-candidiasis-an-animal-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T17:09:58Z","timestamp":1748538598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/335901-development-and-evaluation-of-oro-mucosal-drug-delivery-system-for-the-effective-management-of-oropharyngeal-candidiasis-an-animal-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.85040","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,29]]}}}